Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc for GVHD Prophylaxis in SCT
NCT02167451Phase 2Terminated
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Jul 2014
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of maraviroc in graft-versus-host disease (GVHD), sponsored by Cincinnati Children's Hospital Medical Center. Started Jul 2014; status: terminated.
02
Drugs
maraviroc
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT02167451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02167451.